Causal Relationship between PCSK9 Inhibitor and Atrial Fibrillation/ A Drug Target Mendelian Randomization Study
Clinical Medicine and Pharmacology · 2025
DOI: 10.70731/91pd8g49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine and Pharmacology, 2025. Verfasst von Xinlong Zhang und 2 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In addition to reducing cholesterol levels, proprotein convertase subtilis kexin 9 (PCSK9) inhibitors exhibit pleiotropic effects, including potential prevention of atrial fibrillation; however, their impact on this cardiac arrhythmia remains controversial. To investigate this relationship, we employed drug-target Mendelian randomization (MR) analysis, collecting single-nucleotide polymorphisms (SNPs) of PCSK9 from published genome-wide association study statistics. Our findings demonstrated that PCSK9 inhibitors significantly reduced the risk of atrial fibrillation (OR [95%CI] = 0.59 [0.45 to 0.78], p=1.38×10-4). For comparison, we also evaluated the effects of 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) inhibitors (targeting statins), using coronary heart disease risk as a positive control, and observed that HMGCR inhibitors may conversely increase the risk of atrial fibrillation. These results suggest that PCSK9 inhibitors confer a protective effect against atrial fibrillation, while HMGCR inhibitors could pose a potential risk for this condition.
Zitieren
APA
Zhang, X., Yang, Z., & Huang, R. (2025). Causal Relationship between PCSK9 Inhibitor and Atrial Fibrillation/ A Drug Target Mendelian Randomization Study. Clinical Medicine and Pharmacology. https://doi.org/10.70731/91pd8g49
Vancouver
Zhang X, Yang Z, Huang R. Causal Relationship between PCSK9 Inhibitor and Atrial Fibrillation/ A Drug Target Mendelian Randomization Study. Clinical Medicine and Pharmacology. 2025. doi:10.70731/91pd8g49
BibTeX
@article{Zhang2025,
author = {Zhang, Xinlong and Yang, Zihong and Huang, Rongjie},
title = {Causal Relationship between PCSK9 Inhibitor and Atrial Fibrillation/ A Drug Target Mendelian Randomization Study},
journal = {Clinical Medicine and Pharmacology},
year = {2025},
doi = {10.70731/91pd8g49}
}
EUVIMED